申请人:BLUEPRINT MEDICINES CORPORATION
公开号:US10196436B2
公开(公告)日:2019-02-05
Described herein are inhibitors of FGFR, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit the activity of tyrosine kinases.
本文描述了表皮生长因子受体的抑制剂、包括此类化合物的药物组合物,以及使用此类化合物和组合物抑制酪氨酸激酶活性的方法。